Chao-Yie Yang

Dr. Chao-Yie Yang

Universtiy of Tennessee Health Science Center

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XYXinrui Yuan
Xinrui Yuan
HBHong Bu
Hong Bu
JZJinpei Zhou
Jinpei Zhou
Chao-Yie YangChao-Yie Yang
Chao-Yie Yang
HZHuibin Zhang
Huibin Zhang

10 December 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HZHaibin Zhou
Haibin Zhou
LBLongchuan Bai
Longchuan Bai
RXRenqi Xu
Renqi Xu
Yujun ZhaoYujun Zhao
Yujun Zhao
JCJianyong Chen
Jianyong Chen
SWShaomeng Wang
Shaomeng Wang

21 October 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JYJiuling Yang
Jiuling Yang
YLYangbing Li
Yangbing Li
AAAngelo Aguilar
Angelo Aguilar
ZLZhaomin Liu
Zhaomin Liu
Chao-Yie YangChao-Yie Yang
Chao-Yie Yang
SWShaomeng Wang
Shaomeng Wang

21 May 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MWMingliang Wang
Mingliang Wang
JLJianfeng Lu
Jianfeng Lu
MWMi Wang
Mi Wang
Chao-Yie YangChao-Yie Yang
Chao-Yie Yang
SWShaomeng Wang
Shaomeng Wang

1 October 2018 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
WXWeiguo Xiang
Weiguo Xiang
Chao-Yie YangChao-Yie Yang
Chao-Yie Yang
LBLongchuan Bai
Longchuan Bai
Myeloid cell leukemia-1 (MCL-1), a member of antiapoptotic BCL-2 family proteins, is a key regulator of mitochondrial homeostasis. Frequent overexpression of MCL-1 in human primary and drug-resistant cancer cells makes it an attractive cancer therapeutic target. Significant progress has been made in the development of small-molecule MCL-1 inhibitors in recent years, and three MCL-1 selective inhibitors have advanced to clinical trials. This review briefly discusses recent advances in the development of small molecules targeting MCL-1 for cancer therapy.

8 September 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WXWeiguo Xiang
Weiguo Xiang
LZLijie Zhao
Lijie Zhao
XHXin Han
Xin Han
TXTianfeng Xu
Tianfeng Xu
SKSteven Kregel
Steven Kregel
SWShaomeng Wang
Shaomeng Wang